Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 3Adenoma 2Venous Thromboembolism 1Urinary Bladder Neoplasms 1Thrombocytopenia 1Soft Tissue Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Node Positive HER2 Negative Breast Cancer 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myocardial Infarction 1Multiple Myeloma 1Hereditary Sensory and Autonomic Neuropathies 1Hematuria 1Hematologic Diseases 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adenomatous Polyps 1Adenocarcinoma of Lung 1Acute Coronary Syndrome 1

Interventions

temsirolimus 1Valproic Acid 1Sirolimus 1Immunoglobulin G 1Enoxaparin 1Disulfides 1Cetuximab 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Soft Tissue Neoplasms × Aspirin × Clear all
NCT01965002 2018-05-23

Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors

Stanford University

Phase NA Terminated
5 enrolled 8 charts

Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡